Evidence map›Paper›PMID 29780514›Full record

ArticleChemical science2018

Construction of histidine-containing hydrocarbon stapled cell penetrating peptides for

Soonsil Hyun, Yoonhwa Choi, Ha Neul Lee, Changki Lee, Donghoon Oh, Dong-Ki Lee, Changjin Lee, Yan Lee, Jaehoon Yu

Open access · diamondAbstract read
In one paragraph

Article in Chemical science, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
2.1field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 39 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Review
  7. Article
  8. Review
  9. Article
  10. Article
  11. Review
  12. Article
  13. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 4 countries.

Soonsil HyunInstitute of Molecular Biology and Genetics , Seoul National University , Seoul 08826 , Korea.ORCID 0000-0002-3400-7353
Yoonhwa ChoiDepartment of Chemistry & Education , Seoul National University , Seoul 08826 , Korea . Email: jhoonyu@snu.ac.kr.
Ha Neul LeeHugel, Inc. , Chuncheon 24206 , Korea . Email: senovia@hugel.co.kr.
Changki LeeHugel, Inc. , Chuncheon 24206 , Korea . Email: senovia@hugel.co.kr.
Donghoon OhHugel, Inc. , Chuncheon 24206 , Korea . Email: senovia@hugel.co.kr.
Dong-Ki LeeDepartment of Chemistry , Sungkyunkwan University , Suwon , Korea.
Changjin LeeHugel, Inc. , Chuncheon 24206 , Korea . Email: senovia@hugel.co.kr.
Yan LeeDepartment of Chemistry , Seoul National University , Seoul 08826 , Korea . Email: gacn@snu.ac.kr.ORCID 0000-0003-2498-1301
Jaehoon YuInstitute of Molecular Biology and Genetics , Seoul National University , Seoul 08826 , Korea.ORCID 0000-0003-4222-4398
Seoul National University · KRChuncheon National Hospital · KRSuwon Research Institute · KR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A hydrocarbon stapled peptide based strategy was used to develop an optimized cell penetrating peptide for siRNA delivery. Various stapled peptides, having amphipathic Leu- and Lys-rich regions, were prepared and their cell penetrating potentials were evaluated. One peptide, stEK, was found to have high cell penetration and siRNA delivery abilities at low nanomolar concentrations. In order to improve its ability to promote gene silencing, stEK was modified by replacing several Lys residues with His moieties. The modified peptide, LKH-stEK, was found to facilitate endosomal escape and to display >90% knock-down with 50 nM of a siRNA targeting cyclophilin B in HeLa cells. The results of an

Identifiers

PMID29780514
PMCPMC5939838
OpenAlexW2796249284

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.